Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- OncoTree
- BREAST
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02681640 | uPAR PET/CT for Preoperative Staging of Breast Cancer Patients | completed | Phase 2 | 50 | Rigshospitalet, DenmarkOTHER | 1 | Apr 6, 2017 | clinicaltrials |
| NCT01439945 | Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer | completed | Phase 2 | 289 | Alliance for Clinical Trials in OncologyOTHER | 1 | Apr 4, 2017 | clinicaltrials |
| NCT00679211 |
| A Study of Trastuzumab-Mcc-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer |
| completed |
| Phase 2 |
| 110 |
| Genentech, Inc.INDUSTRY |
| 0 |
| Mar 31, 2017 |
| clinicaltrials |
| NCT01331629 | Impact of Art Therapy on Fatigue and Quality of Life of Patients Treated With Adjuvant Radiotherapy for Breast Cancer(ART-THERAPIE) | completed | Phase 2 / Phase 3 | 322 | Centre Francois BaclesseOTHER | 1 | Mar 14, 2017 | clinicaltrials |
| NCT01654185 | Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer | completed | Phase 2 | 60 | Xichun HuOTHER | 1 | Mar 14, 2017 | clinicaltrials |
| NCT02365805 | Randomized CT to Evaluate Efficacy of Neoadjuvant Chemotherapy Customized by Levels of BRCA1-HER2 Negative Breast Cancer(BERNAQ) | completed | Phase 2 | 30 | Fundación Pública Andaluza para la gestión de la Investigación en SevillaOTHER | 1 | Mar 13, 2017 | clinicaltrials |
| NCT01572727 | A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation(BELLE-4) | completed | Phase 2 / Phase 3 | 416 | Novartis PharmaceuticalsINDUSTRY | 22 | Mar 9, 2017 | clinicaltrials |
| NCT00093808 | Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 47 | Alliance for Clinical Trials in OncologyOTHER | 1 | Mar 6, 2017 | clinicaltrials |
| NCT00247650 | Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy | completed | Phase 2 | 190 | NovartisINDUSTRY | 1 | Mar 1, 2017 | clinicaltrials |
| NCT00086957 | Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 31 | City of Hope Medical CenterOTHER | 1 | Feb 27, 2017 | clinicaltrials |
| NCT00828074 | Sorafenib and Vinorelbine in Treating Women With Stage IV Breast Cancer | completed | Phase 1 / Phase 2 | 46 | City of Hope Medical CenterOTHER | 1 | Feb 27, 2017 | clinicaltrials |
| NCT00182793 | Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer | completed | Phase 2 | 32 | City of Hope Medical CenterOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00303875 | Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are Overweight | completed | Phase 2 | 641 | Duke UniversityOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00570921 | Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure(BRE-43) | completed | Phase 2 | 33 | Mara ChambersOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT01320111 | Breast Cancer Study: Paclitaxel Versus Paclitaxel Plus Sorafenib in Second- or Third-line Treatment(PASO) | completed | Phase 2 | 59 | Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbHOTHER | 1 | Feb 20, 2017 | clinicaltrials |
| NCT00056082 | Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women | completed | Phase 2 | 110 | University of Kansas Medical CenterOTHER | 1 | Feb 15, 2017 | clinicaltrials |
| NCT02583568 | Fluorescence Guided Surgery in Breast Cancer(MARGIN) | completed | Phase 1 / Phase 2 | 26 | University Medical Center GroningenOTHER | 1 | Feb 13, 2017 | clinicaltrials |
| NCT01091974 | Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy | completed | Phase 2 | 138 | University of RochesterOTHER | 1 | Feb 9, 2017 | clinicaltrials |
| NCT00290758 | Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer | completed | Phase 2 | 126 | National Cancer Institute (NCI)NIH | 1 | Feb 8, 2017 | clinicaltrials |
| NCT00976989 | A Study of Pertuzumab in Combination With Herceptin and Chemotherapy in Participants With HER2-Positive Breast Cancer | completed | Phase 2 | 225 | Hoffmann-La RocheINDUSTRY | 20 | Feb 6, 2017 | clinicaltrials |
| NCT01427933 | A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast Cancer | completed | Phase 2 | 141 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 6, 2017 | clinicaltrials |
| NCT00080262 | Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC) | completed | Phase 2 | 125 | R-PharmINDUSTRY | 10 | Jan 30, 2017 | clinicaltrials |
| NCT00826085 | Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall(DIGNITY) | completed | Phase 1 / Phase 2 | 17 | ImunonINDUSTRY | 1 | Jan 30, 2017 | clinicaltrials |
| NCT01027208 | A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline | completed | Phase 2 | 20 | R-PharmINDUSTRY | 1 | Jan 30, 2017 | clinicaltrials |
| NCT02806544 | Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country | completed | Phase 2 | 35 | Vanderbilt UniversityOTHER | 0 | Jan 30, 2017 | clinicaltrials |
| NCT00755885 | Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 77 | Cancer Research UKOTHER | 1 | Jan 26, 2017 | clinicaltrials |
| NCT01356862 | Pasireotide LAR Administration in Lymphocele Prevention After Axillary Node Dissection for Breast Cancer(SOM 230) | completed | Phase 2 | 91 | Alliance Pour La Recherche en CancerologieOTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT02199418 | Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer(SHPD001) | completed | Phase 2 | 132 | RenJi HospitalOTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT01186991 | Study Evaluating the Safety and Efficacy of Onartuzumab And/or Bevacizumab in Combination With Paclitaxel in Participants With Metastatic, Triple Negative Breast Cancer | completed | Phase 2 | 185 | Genentech, Inc.INDUSTRY | 6 | Jan 20, 2017 | clinicaltrials |
| NCT01381315 | Axillary Reverse Mapping | completed | Phase 2 | 210 | University of Kansas Medical CenterOTHER | 1 | Jan 10, 2017 | clinicaltrials |
| NCT00068263 | 3-Dimensional Conformal Radiation Therapy In Treating Women With Stage I or Stage II Breast Cancer Previously Treated With Lumpectomy and Axillary Node Dissection | completed | Phase 1 / Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 1 | Jan 4, 2017 | clinicaltrials |
| NCT00572728 | Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer | completed | Phase 2 | 90 | National Cancer Institute (NCI)NIH | 1 | Dec 30, 2016 | clinicaltrials |
| NCT01252290 | Breast Cancer Risk Biomarkers in Postmenopausal Women | completed | Phase 2 | 35 | Carol Fabian, MDOTHER | 1 | Dec 16, 2016 | clinicaltrials |
| NCT00079118 | Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer | completed | Phase 2 | 70 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 13, 2016 | clinicaltrials |
| NCT00275041 | Irinotecan and Cetuximab in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 21 | Alliance for Clinical Trials in OncologyOTHER | 0 | Dec 13, 2016 | clinicaltrials |
| NCT00005963 | Docetaxel and Carboplatin in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 53 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 7, 2016 | clinicaltrials |
| NCT00006007 | LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 59 | Alliance for Clinical Trials in OncologyOTHER | 2 | Dec 7, 2016 | clinicaltrials |
| NCT00059852 | Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane | completed | Phase 2 | 61 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 7, 2016 | clinicaltrials |
| NCT00088998 | Docetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 46 | Alliance for Clinical Trials in OncologyOTHER | 0 | Dec 7, 2016 | clinicaltrials |
| NCT01075100 | Ixabepilone + Carboplatin Metastatic Breast Cancer | completed | Phase 2 | 103 | US Oncology ResearchINDUSTRY | 1 | Dec 7, 2016 | clinicaltrials |
| NCT00008320 | Ceramide Cream in Treating Women With Cutaneous Breast Cancer | completed | Phase 2 | 26 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 6, 2016 | clinicaltrials |
| NCT00265733 | Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 48 | Alliance for Clinical Trials in OncologyOTHER | 0 | Dec 6, 2016 | clinicaltrials |
| NCT01738438 | Cabozantinib for Metastatic Triple Negative BrCa | completed | Phase 2 | 35 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 6, 2016 | clinicaltrials |
| NCT01565083 | A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer(VELVET) | completed | Phase 2 | 213 | Hoffmann-La RocheINDUSTRY | 7 | Nov 22, 2016 | clinicaltrials |
| NCT02748213 | A Study of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Advanced and/or Metastatic Breast Cancer | completed | Phase 2 | 225 | Hoffmann-La RocheINDUSTRY | 15 | Nov 22, 2016 | clinicaltrials |
| NCT00291694 | Protocol for Women at Increased Risk of Developing Breast Cancer | completed | Phase 2 | 72 | Carol Fabian, MDOTHER | 1 | Nov 7, 2016 | clinicaltrials |
| NCT00303108 | Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer | completed | Phase 2 | 136 | US Oncology ResearchINDUSTRY | 1 | Nov 3, 2016 | clinicaltrials |
Data updated 24 days agoSource updated Apr 6, 2017source: clinicaltrials